Conclusion
In conclusion, sepsis is still an important clinical challenge for ICUs with few therapeutic options. This chapter has summarized the current knowledge on RAGE, an inflammation perpetuating receptor, which plays a pivotal role in sepsis. RAGE is involved in signal transduction from pathogen substrates to cell activation during the onset of inflammation and perpetuates the immune response. Targeting this receptor might attenuate hyperinflammation. Essentially, understanding of the basic signal transduction of these receptors may offer new diagnostic and therapeutic options in septic patients.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Bouchon A, Facchetti F, Weigand MA, Colonna M (2001) TREM-1 amplifies inflammation and is a crucial mediator of septic shock. Nature 410:1103–1107
Weigand MA, Horner C, Bardenheuer HJ, Bouchon A (2004) The systemic inflammatory response syndrome. Best Pract Res Clin Anaesthesiol 18:455–75
Neeper M, Schmidt AM, Brett J, et al (1992) Cloning and expression of a cell surface receptor for advanced glycosilation endproducts of proteins. J Biol Chem 267:14998–15004
Schmidt AM, Vianna M, Gerlach M, et al (1992) Isolation and characterization of two binding proteins for advanced glycosylation end products from bovine lung which are present on the endothelial cell surface. J Biol Chem 267:14987–4997
Isermann B, Bierhaus A, Humpert PM, et al (2004) AGE-RAGE: A hypothesis or a mechanism? Herz 29:504–509
Bierhaus A, Humpert PM, Morcos M, et al (2005) Understanding RAGE, the receptor for advanced glycation end products. J Mol Med 83:876–886
Huttunen HJ, Rauvala H (2004) Amphoterin as an extracellular regulator of cell motility: from discovery to disease. J Intern Med 255:351–366
Ritthaler U, Deng Y, Zhang Y, et al (1995) Expression of receptors for advanced glycation end products in peripheral occlusive vascular disease. Am J Pathol 146:688–694
Sousa MM, Yan SD, Stern D, Saraiva MJ (2000) Interaction of the receptor for advanced glycation end products (RAGE) with transthyretin triggers nuclear transcription factor kB (NF-kB) activation. Lab Invest 80:1101–1110
Degryse B, Bonaldi T, Scaffidi P, et al (2001) The high mobility group (HMG) boxes of the nuclear protein HMG1 induce chemotaxis and cytoskeleton reorganization in rat smooth muscle cells. J Cell Biol 152:1197–1206
Sugaya K, Fukagawa T, Matsumoto K, et al (1994) Three genes in the human MHC class III region near the junction with the class II: gene for receptor of advanced glycosylation end products, PBX2 homeobox gene and a notch homolog, human counterpart of mouse mammary tumor gene int-3. Genomics 23:408–419
Hofmann MA, Drury S, Hudson BI, et al (2002) RAGE and arthritis: the G82S polymorphism amplifies the inflammatory response. Genes Immun 3:123–135
Hofmann MA, Drury S, Fu C, et al (1999) RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell 97:889–901
Ishihara K, Tsutsumi K, Kawane S, Nakajima M, Kasaoka T (2003) The receptor for advanced glycation end-products (RAGE) directly binds to ERK by a D-domain-like docking site. FEBS Lett 550:107–113
Simm A, Bartling B, Silber RE (2004) RAGE: a new pleiotropic antagonistic gene? Ann N Y Acad Sci 1019:228–231
Schmidt AM, Yan SD, Yan SF, Stern DM (2000) The biology of the receptor for advanced glycation end products and ist ligands. Biochim Biophys Acta 1498:99–111
Thornalley PJ (1998) Cell activation by glycated proteins. AGE receptors, receptor recognition factors and functional classification of AGEs. Cell Mol Biol (Noisy-le-grand) 44:1013–1023
Yan SSD, Wu ZY, Zhang HP, et al (2003) Suppression of experimental autoimmune encephalomyelitis by selective blockade of encephalitogenic T-cell infiltration of the central nervous system. Nat Med 9:287–293
Lotze MT, Tracey KJ (2005) High-mobility group box 1 protein (HMGB1): Nuclear weapon in the immune arsenal. Nat Rev 5:331–342
Shanmugam N, Kim YS, Lanting L, Natarajan R (2003) Regulation of cyclooxygenase-2 expression in monocytes by ligation of the receptor for advanced glycation end products. J Biol Chem 278:34834–34844
Rammes A, Roth J, Goebeler M, Klempt M, Hartmann M, Sorg C (1997) Myeloid-related protein (MRP) 8 and MRP14, calcium-binding proteins of the S100 family, are secreted by activated monocytes via a novel, tubulin-dependent pathway. J Biol Chem 272:9496–9502
Weigand MA, Volkmann M, Schmidt H, Martin E, Bohrer H, Bardenheuer HJ (2000) Neuron-specific enolase as a marker of fatal outcome in patients with severe sepsis or septic shock. Anesthesiology 92:905–907
Taguchi A, Blood DC, del Toro G, et al (2000) Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases. Nature 405:354–360
Andersson U, Wang H, Palmblad K, et al (2000) High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes. J Exp Med 192:565–570
Wang H, Bloom O, Zhang M, et al (1999) HMGB-1 as a late mediator of endotoxin lethality in mice. Science 285:248–251
Yang H, Ochani M, Li J, et al (2004) Reversing established sepsis with antagonists of endogenous high-mobility group box 1. Proc Natl Acad Sci USA 101:296–301
Rouhiainen A, Kuja-Panula J, Wilkman E, et al (2004) Regulation of monocyte migration by amphoterin (HMGB-1). Blood 104:1174–1182
Sappington PL, Yang R, Yang H, Tracey KJ, Delude RL, Fink MP (2002) HMGB-1 B box increases the permeability of Caco-2 enterocytic monolayers and impairs intestinal barrier function in mice. Gastroenterology 123:790–802
Kokkola R, Andersson A, Mullins G, et al (2005) RAGE is the major receptor for the proinflammatory activity of HMGB-1 in rodent macrophages. Scand J Immunol 61:1–9
Abraham E, Arcaroli J, Carmody A, Wang H, Tracey KJ (2000) HMG-1 as a mediator of acute lung inflammation. J Immunol 165:2950–2954
Ulloa L, Ochani M, Yang H, et al (2002) Ethyl pyruvate prevents lethality in mice with established lethal sepsis and systemic inflammation. Proc Natl Acad Sci USA 99:12351–12356
Liliensiek B, Weigand MA, Bierhaus A, et al (2004) Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response. J Clin Invest 113:1641–1650
Zeng S, Feirt N, Goldstein M, et al (2004) Blockade of receptor for advanced glycation end product (RAGE) attenuates ischemia and reperfusion injury to the liver in mice. Hepatology 39:422–432
Cataldegirmen C, Zeng S, Feirt N, et al (2005) RAGE limits regeneration after massive liver injury by coordinated suppression of TNF-k and NF-kB. J Exp Med 201:473–484
Chavakis T, Bierhaus A, Al-Fakhri N, et al (2003) The pattern recognition receptor (RAGE) is a counterreceptor for leukocyte integrins: a novel pathway for inflammatory cell recruitment. J Exp Med 198:1507–1515
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Weigand, M.A., Bopp, C., Böttiger, B.W. (2006). The Emerging Role of RAGE in Sepsis. In: Vincent, JL. (eds) Yearbook of Intensive Care and Emergency Medicine. Yearbook of Intensive Care and Emergency Medicine, vol 2006. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-33396-7_2
Download citation
DOI: https://doi.org/10.1007/3-540-33396-7_2
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-30155-4
Online ISBN: 978-3-540-33396-8
eBook Packages: MedicineMedicine (R0)